These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 3556279)
1. Treatment with anti-T-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozocin. Herold KC; Montag AG; Fitch FW Diabetes; 1987 Jul; 36(7):796-801. PubMed ID: 3556279 [TBL] [Abstract][Full Text] [Related]
2. Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Koike T; Itoh Y; Ishii T; Ito I; Takabayashi K; Maruyama N; Tomioka H; Yoshida S Diabetes; 1987 Apr; 36(4):539-41. PubMed ID: 3102302 [TBL] [Abstract][Full Text] [Related]
3. L3T4 and Lyt-2 T cells are both involved in the generation of low-dose streptozotocin-induced diabetes in mice. Kantwerk G; Cobbold S; Waldmann H; Kolb H Clin Exp Immunol; 1987 Dec; 70(3):585-92. PubMed ID: 2963718 [TBL] [Abstract][Full Text] [Related]
4. Anti-interleukin 2 receptor antibody attenuates low-dose streptozotocin-induced diabetes in mice. Hatamori N; Yokono K; Hayakawa M; Taki T; Ogawa W; Nagata M; Hari J; Shii K; Taniguchi H; Baba S Diabetologia; 1990 May; 33(5):266-71. PubMed ID: 2142923 [TBL] [Abstract][Full Text] [Related]
5. Induction of insulitis by adoptive transfer with L3T4+Lyt2- T-lymphocytes in T-lymphocyte-depleted NOD mice. Hanafusa T; Sugihara S; Fujino-Kurihara H; Miyagawa J; Miyazaki A; Yoshioka T; Yamada K; Nakajima H; Asakawa H; Kono N Diabetes; 1988 Feb; 37(2):204-8. PubMed ID: 3292315 [TBL] [Abstract][Full Text] [Related]
6. Administration of silica particles or anti-Lyt2 antibody prevents beta-cell destruction in NOD mice given cyclophosphamide. Charlton B; Bacelj A; Mandel TE Diabetes; 1988 Jul; 37(7):930-5. PubMed ID: 2838358 [TBL] [Abstract][Full Text] [Related]
7. Diabetes induced with low doses of streptozotocin is mediated by V beta 8.2+ T-cells. Herold KC; Bloch TN; Vezys V; Sun Q Diabetes; 1995 Mar; 44(3):354-9. PubMed ID: 7883124 [TBL] [Abstract][Full Text] [Related]
10. The role of thymic immunity and insulitis in the development of streptozocin-induced diabetes in mice. Nakamura M; Nagafuchi S; Yamaguchi K; Takaki R Diabetes; 1984 Sep; 33(9):894-900. PubMed ID: 6236118 [TBL] [Abstract][Full Text] [Related]
11. Heparin attenuates low-dose streptozotocin-induced immune diabetes in mice and inhibits the beta-cell binding of T-splenocytes in vitro. Saï P; Pogu S; Ouary M Diabetologia; 1991 Apr; 34(4):212-7. PubMed ID: 2065856 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of streptozocin-induced insulitis and diabetes with lobenzarit in CD-1 mice. Iwakiri R; Nagafuchi S Diabetes; 1989 May; 38(5):558-61. PubMed ID: 2653927 [TBL] [Abstract][Full Text] [Related]
14. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. Miller BJ; Appel MC; O'Neil JJ; Wicker LS J Immunol; 1988 Jan; 140(1):52-8. PubMed ID: 3275717 [TBL] [Abstract][Full Text] [Related]